Table 1 Patient characteristics and perioperative data at different time to LARS assessment
From: The status of low anterior resection syndrome: data from a single-center in China
Variable | Postoperative time to LARS assessment (months) | P value | ||
|---|---|---|---|---|
≤ 12 (n = 68) | 12–36 (n = 115) | ≥ 36 (n = 78) | ||
Sex | 0.508 | |||
Male | 42 | 74 | 55 | |
Female | 26 | 41 | 23 | |
Age (year) | 62.22 + 11.39 | 61.26 + 10.09 | 59.88 + 11.85 | 0.431 |
<60 | 28 | 43 | 32 | 0.831 |
≥60 | 40 | 72 | 46 | |
BMI (kg/m2) | 22.58 + 2.96 | 22.54 + 3.57 | 23.07 + 3.27 | 0.519 |
T-stage | 0.453 | |||
T1 − 2 | 24 | 44 | 23 | |
T3 − 4 | 44 | 71 | 55 | |
N-stage | 0.541 | |||
N0 | 46 | 81 | 49 | |
N1 − 2 | 22 | 34 | 29 | |
Tumor height | 0.152 | |||
≤5 cm | 17 | 35 | 18 | |
5-10 cm | 44 | 56 | 42 | |
≥10 cm | 7 | 24 | 18 | |
Total mesorectal excision | 0.523 | |||
Yes | 18 | 35 | 18 | |
No | 50 | 80 | 60 | |
Excision excision | 0.988 | |||
Yes | 2 | 3 | 2 | |
No | 66 | 112 | 76 | |
Hyperlipemia | ||||
Yes | 4 | 12 | 6 | 0.542 |
No | 64 | 103 | 72 | |
Diabetes | 0.889 | |||
Yes | 9 | 16 | 9 | |
No | 59 | 99 | 69 | |
Protective stoma | ||||
Yes | 11 | 22 | 17 | 0.642 |
No | 57 | 93 | 59 | |
Neoadjuvant therapy | ||||
Yes | 27 | 40 | 21 | 0.251 |
No | 41 | 75 | 57 | |